US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 3.950
  • +1.620+69.53%
Close Apr 23 16:00 ET
  • 3.790
  • -0.160-4.05%
Post 20:01 ET
6.38MMarket Cap-1.75P/E (TTM)

About Sonoma Pharmaceuticals Company

Sonoma Pharmaceuticals, Inc. engages in the development and production of hypochlorous acid (HOCl) products for wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.

Company Profile

SymbolSNOA
Company NameSonoma Pharmaceuticals
Listing DateJan 25, 2007
Issue Price4.95
Founded1999
CEOMs. Amy Trombly
MarketNASDAQ
Employees172
Fiscal Year Ends03-31
Address5445 Conestoga Court,Suite 150
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-800-759-9305

Company Executives

  • Name
  • Position
  • Salary
  • Amy Trombly
  • Director, President and Chief Executive Officer
  • 726.54K
  • Jerome J. Dvonch
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Bruce Thornton
  • Executive Vice President, Chief Operating Officer and Corporate Secretary
  • 658.67K
  • Philippe Weigerstorfer
  • Independent Director
  • 47.50K
  • Jerry McLaughlin
  • Lead Independent Director
  • 65.00K
  • Dr. Jay Edward Birnbaum
  • Independent Director
  • 55.00K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More